PEGASYS Side Effects

6924099-3 | Autoimmune Hepatitis, Pneumocystis Jiroveci Pneumonia
on Aug 04, 2010 Male patient from JAPAN , 51 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune hepatitis, pneumocystis jiroveci pneumonia. Pegasys dosage: Note: Dosage Is Uncertain.. During the same period patient was treated with COPEGUS (Note: Dosage Is Uncertain.) (View Copegus Review and Copegus Label ), PEG INTRON (Note: Dosage Is Uncertain.) (View Peg-intron Review and Peg-intron Label ). Patient was hospitalized.

6923276-5 | Hypokalaemia
Patient was taking Pegasys (View Usage). Patient had the following side effects: hypokalaemia on Aug 04, 2010 from JAPAN Additional patient health information: Female patient , 80 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: Note: Dosage Is Uncertain.. Patient was hospitalized.

6923204-2 | Blood Triglycerides Increased, High Density Lipoprotein Increased
Adverse event was reported on Aug 05, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED KINGDOM , weighting 185.2 lb, After Pegasys was administered, patient had the following side effects: blood triglycerides increased, high density lipoprotein increased. During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ).

6923182-6 | Cerebral Infarction
on Aug 04, 2010 Male patient from JAPAN , 68 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), TELMISARTAN (Dose Form: Peroral Agent) (View Telmisartan Review and Telmisartan Label ).


6923178-4 | Gastroenteritis Eosinophilic
on Aug 06, 2010 Male patient from JAPAN , weighting 136.7 lb, was treated with Pegasys (View Usage). Patient had the following side effects: gastroenteritis eosinophilic. Pegasys dosage: . During the same period patient was treated with URSO 250 (Form: Peroral Agent.) (View Urso 250 Review and Urso 250 Label ), SEREVENT (Note: Dosage Is Uncertain.) (View Serevent Review and Serevent Label ), FLUTIDE (Note: Dosage Is Uncertain.) (View Flutide Review and Flutide Label ), LAC B (View Lac-b Review and Lac-b Label ). Patient was hospitalized.

6923151-6 | Anxiety Disorder, Confusional State, Delirium, Hallucination, Visual, Paranoia, Self-injurious Ideation
Patient was taking Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: anxiety disorder, confusional state, delirium, hallucination, visual, paranoia, self-injurious ideation on Aug 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 216.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6920996-3 | Amnesia, Anxiety, Dementia Alzheimer's Type, Depression, Fall, Furuncle, Herpes Zoster, Menopausal Symptoms, Pain
Adverse event was reported on Aug 05, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: Form: Pre-filled Syringe) was diagnosed with hepatitis c (What is hepatitis c?), pain (What is pain?), tremor and. Location: UNITED STATES , weighting 160.3 lb, Patient experienced the following unwanted or unexpected effects: amnesia, anxiety (What is anxiety?), dementia alzheimer's type, depression (What is depression?), fall (What is fall?), furuncle, herpes zoster, menopausal symptoms, pain (What is pain?). During the same period patient was treated with VALIUM (View Valium Review and Valium Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), RIBASPHERE (Divided Doses) (View Ribasphere Review and Ribasphere Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), VALTREX (View Valtrex Review and Valtrex Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), LAMICTAL (View Lamictal Review and Lamictal Label ).

6919255-4 | Abasia, Ataxia, Neuropathy Peripheral
on Aug 04, 2010 Male patient from UNITED STATES , 58 years of age, was treated with Pegasys (View Usage). Patient had the following side effects: abasia, ataxia (What is ataxia?), neuropathy peripheral. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6919164-0 | Blood Triglycerides Increased, High Density Lipoprotein Increased
on Aug 05, 2010 Male patient from UNITED KINGDOM , weighting 185.2 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: blood triglycerides increased, high density lipoprotein increased. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ).

6910728-7 | Anaemia, Deafness, Tinnitus
Patient was taking Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, deafness, tinnitus (What is tinnitus?) on Jul 29, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 179.9 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), PROCRIT (View Procrit Review and Procrit Label ).

6910715-9 | Hepatic Cirrhosis, Laboratory Test Abnormal
Adverse event was reported on Aug 02, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: IRAN (ISLAMIC REPUBLIC OF) , 45 years of age, Patient had the following side effects: hepatic cirrhosis, laboratory test abnormal.

6910714-7 | Hypochloraemia, Hyponatraemia
on Jul 28, 2010 Female patient from GERMANY , 66 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: hypochloraemia, hyponatraemia. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ). Patient was hospitalized.

6908276-3 | Cerebral Haemorrhage, Platelet Count Decreased
on Jul 28, 2010 Male patient from JAPAN , weighting 155.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, platelet count decreased. Pegasys dosage: Note:90-135 Mcg/week.. During the same period patient was treated with EPOGIN (View Epogin Review and Epogin Label ), OXAROL (Note: 5-7.5 Mcg/week.) (View Oxarol Review and Oxarol Label ), MICARDIS (View Micardis Review and Micardis Label ).

6908230-1 | Aplastic Anaemia, Disseminated Intravascular Coagulation, Febrile Neutropenia, Haemorrhagic Diathesis, Jaundice, Petechiae, Pneumonia
Patient was taking Pegasys (View Usage). Patient had the following side effects: aplastic anaemia, disseminated intravascular coagulation, febrile neutropenia, haemorrhagic diathesis, jaundice (What is jaundice?), petechiae, pneumonia (What is pneumonia?) on Jul 28, 2010 from JAPAN Additional patient health information: Female patient , weighting 110.2 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: Form: Injection, Dosage Uncertain. During the same period patient was treated with COPEGUS (Dosage Uncertain) (View Copegus Review and Copegus Label ). Patient was hospitalized.

6902428-4 | Cutaneous Sarcoidosis
Adverse event was reported on Aug 02, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: 180 Weekly Sq) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 45 years of age, weighting 154.3 lb, After Pegasys was administered, patient had the following side effects: cutaneous sarcoidosis.

6901786-4 | Alopecia, Anaemia, Anxiety, Chills, Diarrhoea, Disturbance In Attention, Loss Of Employment, Lymphocyte Count Decreased, Muscle Atrophy
on Aug 02, 2010 Female patient from UNITED STATES , 51 years of age, weighting 140.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, anaemia, anxiety (What is anxiety?), chills, diarrhoea, disturbance in attention, loss of employment, lymphocyte count decreased, muscle atrophy. Pegasys dosage: 180 Iu Weekly Sq.

6895671-4 | Fatigue, Gait Disturbance, Hepatic Cirrhosis, Irritability, Mental Disorder, Multiple Injuries, Nail Disorder, Oedema Peripheral, Onychomadesis
on Jul 30, 2010 Male patient from UNITED STATES , 47 years of age, weighting 255.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient had the following side effects: fatigue, gait disturbance, hepatic cirrhosis, irritability, mental disorder, multiple injuries, nail disorder, oedema peripheral, onychomadesis. Pegasys dosage: Injection 1x / Week Sq. During the same period patient was treated with RIBAVIRIN (2 Pills Per Day Po) (View Ribavirin Review and Ribavirin Label ).

6888381-0 | Basedow's Disease, Chest Pain, Dyspnoea, Hydrothorax, Pleural Disorder, Pyrexia
Patient was taking Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: basedow's disease, chest pain (What is chest pain?), dyspnoea, hydrothorax, pleural disorder (What is pleural disorder?), pyrexia on Jul 17, 2010 from TUNISIA Additional patient health information: Female patient , 52 years of age, . Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ). Patient was hospitalized.

6887771-X | Anaemia, Hepatitis C
Adverse event was reported on Jul 22, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: CHILE , weighting 97.00 lb, Patient experienced the following unwanted or unexpected effects: anaemia, hepatitis c (What is hepatitis c?). During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

6887763-0 | Asthenia, Fatigue, Hypotension, Loss Of Consciousness
on Jul 21, 2010 Male patient from UNITED KINGDOM , weighting 185.2 lb, was treated with Pegasys (View Usage). Patient had the following side effects: asthenia, fatigue, hypotension, loss of consciousness. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6882961-4 | Ascites, Asthenia, Fatigue, Oedema Peripheral
on Jul 23, 2010 Male patient from POLAND , 62 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: ascites, asthenia, fatigue, oedema peripheral. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

6882906-7 | Acute Myocardial Infarction
Patient was taking Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction on Jul 20, 2010 from BRAZIL Additional patient health information: Male patient , 45 years of age, . Pegasys dosage: .

6882724-X | Arteriosclerosis, Blood Cholesterol Abnormal, Myocardial Infarction
Adverse event was reported on Jul 19, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: Form: Injection) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 183.0 lb, Patient had the following side effects: arteriosclerosis, blood cholesterol abnormal, myocardial infarction. During the same period patient was treated with COPEGUS (08 Tablets Daily) (View Copegus Review and Copegus Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ). Patient was hospitalized.

6882679-8 | Paraesthesia, Viith Nerve Paralysis
on Jul 16, 2010 Female patient from TUNISIA , weighting 176.4 lb, was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: paraesthesia, viith nerve paralysis. Pegasys dosage: Frequency:once A Week. During the same period patient was treated with COPEGUS (Frequency Daily) (View Copegus Review and Copegus Label ). Patient was hospitalized.

6876853-4 | Cerebral Haemorrhage, Platelet Count Decreased
on Jul 20, 2010 Male patient from JAPAN , weighting 155.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, platelet count decreased. Pegasys dosage: Note:90-135 Mcg/week.. During the same period patient was treated with EPOGIN (View Epogin Review and Epogin Label ), OXAROL (Note: 5-7.5 Mcg/week.) (View Oxarol Review and Oxarol Label ), MICARDIS (View Micardis Review and Micardis Label ).

6876830-3 | Hepatic Encephalopathy
Patient was taking Pegasys (View Usage). Patient had the following side effects: hepatic encephalopathy on Jul 19, 2010 from TUNISIA Additional patient health information: Female patient , 65 years of age, weighting 149.9 lb, . Pegasys dosage: Dose Reported As: 180 Microg/wk. During the same period patient was treated with COPEGUS (Frequency: Daily, Stop Date Reported As Nc) (View Copegus Review and Copegus Label ). Patient was hospitalized.

6872278-6 | Abdominal Pain, Asthenia, Cytolytic Hepatitis, Jaundice
Adverse event was reported on Jul 13, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: Units: Microg) . Location: TUNISIA , weighting 130.1 lb, After Pegasys was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, cytolytic hepatitis, jaundice (What is jaundice?). During the same period patient was treated with COPEGUS (Frequency: Daily) (View Copegus Review and Copegus Label ). Patient was hospitalized.

6871273-0 | Amnesia, Petit Mal Epilepsy
on Jul 15, 2010 Female patient from UNITED STATES , 41 years of age, was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, petit mal epilepsy. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ).

6871189-X | Paraesthesia, Viith Nerve Paralysis
on Jul 16, 2010 Female patient from TUNISIA , weighting 176.4 lb, was treated with Pegasys (View Usage). Patient had the following side effects: paraesthesia, viith nerve paralysis. Pegasys dosage: Frequency:once A Week. During the same period patient was treated with COPEGUS (Frequency Daily) (View Copegus Review and Copegus Label ). Patient was hospitalized.

6866937-9 | Animal Bite, Rash, White Blood Cell Count Abnormal
Patient was taking Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: animal bite (What is animal bite?), rash (What is rash?), white blood cell count abnormal on Jul 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 198.0 lb, was diagnosed with hypertension, depression (What is depression?), nausea (What is nausea?) and. Pegasys dosage: Pre-filled Syringe,. During the same period patient was treated with COPEGUS (Divided Doses) (View Copegus Review and Copegus Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), PHENERGAN (Co-indication:vomiting) (View Phenergan Review and Phenergan Label ), BUSPAR (Co-indication:anxiety) (View Buspar Review and Buspar Label ).

6862781-7 | Anaemia, Renal Failure
Adverse event was reported on Jul 16, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: ) . Location: TUNISIA , weighting 152.1 lb, Patient experienced the following unwanted or unexpected effects: anaemia, renal failure. During the same period patient was treated with COPEGUS (Frequency; Daily) (View Copegus Review and Copegus Label ).

6860605-5 | Anaemia, Nodule, Oedema
on Jul 12, 2010 Female patient from CANADA , 45 years of age, was treated with Pegasys (View Usage). Patient had the following side effects: anaemia, nodule, oedema. Pegasys dosage: .

6860420-2 | Anaemia, Cardiogenic Shock, Myocardial Infarction
on Jul 12, 2010 Male patient from UNITED STATES , weighting 225.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: anaemia, cardiogenic shock, myocardial infarction. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), PROCRIT (View Procrit Review and Procrit Label ). Patient was hospitalized.

6860039-3 | Bipolar Disorder, Psychotic Disorder
Patient was taking Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: bipolar disorder (What is bipolar disorder?), psychotic disorder (What is psychotic disorder?) on Jul 19, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 220.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: 180 Mcg Wkly Sq. During the same period patient was treated with COPEGUS (600 Mg Bid Oral) (View Copegus Review and Copegus Label ). Patient was hospitalized.

6856555-0 | Abdominal Pain, Circulatory Collapse, Colitis Ulcerative, Confusional State, Convulsion, Dizziness, Epigastric Discomfort, Hypertension, Paraesthesia
Adverse event was reported on Jul 12, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: ) . Location: AUSTRALIA , 37 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), circulatory collapse, colitis ulcerative, confusional state, convulsion, dizziness (What is dizziness?), epigastric discomfort, hypertension, paraesthesia. Patient was hospitalized.

6856537-9 | Vitreous Detachment
on Jul 08, 2010 Male patient from SWEDEN , 70 years of age, was diagnosed with hepatitis (What is hepatitis?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: vitreous detachment. Pegasys dosage: . During the same period patient was treated with ALVEDON (View Alvedon Review and Alvedon Label ), NASONEX (View Nasonex Review and Nasonex Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), COPEGUS (View Copegus Review and Copegus Label ), XERODENT (View Xerodent Review and Xerodent Label ). Patient was hospitalized.

6856395-2 | Amnesia, Anxiety, Dementia Alzheimer's Type, Depression, Fall, Furuncle, Herpes Zoster, Menopausal Symptoms, Pain
on Jul 07, 2010 Female patient from UNITED STATES , weighting 160.3 lb, was diagnosed with hepatitis c (What is hepatitis c?), pain (What is pain?), tremor and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, anxiety (What is anxiety?), dementia alzheimer's type, depression (What is depression?), fall (What is fall?), furuncle, herpes zoster, menopausal symptoms, pain (What is pain?). Pegasys dosage: Form: Pre-filled Syringe. During the same period patient was treated with VALIUM (View Valium Review and Valium Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), RIBASPHERE (Divided Doses) (View Ribasphere Review and Ribasphere Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), VALTREX (View Valtrex Review and Valtrex Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), LAMICTAL (View Lamictal Review and Lamictal Label ).

6848295-9 | Asthma, Bronchial Hyperreactivity, Chest Pain, Cough
Patient was taking Pegasys (View Usage). Patient had the following side effects: asthma (What is asthma?), bronchial hyperreactivity, chest pain (What is chest pain?), cough on Jul 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 143.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: Form: Prefillled Syringe. During the same period patient was treated with RIBAVIRIN (Divided Doses) (View Ribavirin Review and Ribavirin Label ).

6848277-7 | Cryoglobulinaemia, Diarrhoea, Malaise, Mononeuropathy Multiplex, Nausea
Adverse event was reported on Jul 08, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: ) . Location: JAPAN , 67 years of age, After Pegasys was administered, patient had the following side effects: cryoglobulinaemia, diarrhoea, malaise, mononeuropathy multiplex, nausea (What is nausea?). During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6848269-8 | Subarachnoid Haemorrhage
on Jul 06, 2010 Female patient from JAPAN , weighting 97.00 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: subarachnoid haemorrhage. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6844358-2 | Disseminated Intravascular Coagulation, Still's Disease Adult Onset
on Jul 05, 2010 Female patient from JAPAN , weighting 132.3 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient had the following side effects: disseminated intravascular coagulation, still's disease adult onset. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ), MAINTATE (View Maintate Review and Maintate Label ). Patient was hospitalized.

6840026-1 | Autoimmune Hepatitis, Blood Pressure Increased, Insomnia
Patient was taking Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: autoimmune hepatitis, blood pressure increased, insomnia on Jul 07, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: Prefilled Syringe. During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), ZESTRIL (View Zestril Review and Zestril Label ).

6840015-7 | Anaemia, Interstitial Lung Disease
Adverse event was reported on Jul 07, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with therapeutic procedure and. Location: FRANCE , 62 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: anaemia, interstitial lung disease. During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ). Patient was hospitalized.

6840005-4 | Anaemia, Asthenia, Chromaturia, Dizziness, Epistaxis, Eye Haemorrhage, Fatigue, Influenza Like Illness
on Jul 07, 2010 Female patient from UNITED STATES , weighting 203.9 lb, was diagnosed with hepatitis c (What is hepatitis c?), hypertension and was treated with Pegasys (View Usage). Patient had the following side effects: anaemia, asthenia, chromaturia, dizziness (What is dizziness?), epistaxis, eye haemorrhage, fatigue, influenza like illness. Pegasys dosage: Form: Pre-filled Syringe. During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), LIDODERM (View Lidoderm Review and Lidoderm Label ), CARVEDILOL (Dose: 3.125 Frequency: Qd) (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.

6836151-1 | Alopecia, Anaemia, Cutaneous Sarcoidosis, Phlebitis, Psoriasis, Pulmonary Fibrosis, Scleroderma
on Jul 06, 2010 Female patient from FRANCE , 63 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: alopecia, anaemia, cutaneous sarcoidosis, phlebitis, psoriasis, pulmonary fibrosis (What is pulmonary fibrosis?), scleroderma (What is scleroderma?). Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6832098-5 | Depression, Homicide
Patient was taking Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), homicide on Jul 07, 2010 from CHINA Additional patient health information: Male patient , 44 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ).

6826894-8 | Adenocarcinoma
Adverse event was reported on Jul 01, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: ) . Location: LEBANON , 55 years of age, Patient had the following side effects: adenocarcinoma. During the same period patient was treated with RIBAVIRIN (Dose, Form,frequency Not Reported.) (View Ribavirin Review and Ribavirin Label ).

6826874-2 | Appendicitis
on Jul 01, 2010 Male patient from LEBANON , 50 years of age, was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: appendicitis (What is appendicitis?). Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ). Patient was hospitalized.

6819907-0 | Alopecia, Arthralgia, Chronic Obstructive Pulmonary Disease, Convulsion, Depression, Dry Skin, Feeling Of Body Temperature Change, Hepatic Cirrhosis, Myalgia
on Jun 28, 2010 Male patient from UNITED STATES , weighting 229.9 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, arthralgia, chronic obstructive pulmonary disease, convulsion, depression (What is depression?), dry skin, feeling of body temperature change, hepatic cirrhosis, myalgia. Pegasys dosage: Form: Injection. During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6817302-1 | Haematoma, Thrombocytopenia
Patient was taking Pegasys (View Usage). Patient had the following side effects: haematoma, thrombocytopenia on Jun 24, 2010 from SPAIN Additional patient health information: Female patient , 35 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: . During the same period patient was treated with REBETOL (View Rebetol Review and Rebetol Label ).